Principal Investigator
Marijo Bilusic
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240310
Clinical Trial Summary
A Phase 1/2 Platform Study to Evaluate the Safety and Efficacy of MK-5684-based Investigational Treatments in Participants With
Prostate Cancer
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
305-243-2647